Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Chevallard Daniel R. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/26/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,635 shares @ $1.4196, valued at $5.2k
Exercised 6,889 restricted stock units @ $0
05/26/2023 144 Form 144 - Report of proposed sale of securities:
03/17/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 200,000 options to buy @ $1.65, valued at $330k
02/28/2023 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,599 shares @ $1.6812, valued at $6.1k
Exercised 6,889 restricted stock units @ $0
11/29/2022 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,532 shares @ $2.7196, valued at $9.6k
Exercised 6,889 restricted stock units @ $0
08/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2021 144 Form 144 - Report of proposed sale of securities:
11/29/2021 4 Chevallard Daniel R. (CFO and COO) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Sold 3,254 shares @ $4.8006, valued at $15.6k
Sold 4,325 shares @ $4.8191, valued at $20.8k
Exercised 13,777 restricted stock units @ $0
09/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
07/02/2019 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 2,669 shares @ $1.3115, valued at $3.5k
05/16/2019 4/A Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 8,000 options to buy @ $0.95, valued at $7.6k
05/16/2019 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 55,414 shares @ $0
Sold 10,000 shares @ $1.4089, valued at $14.1k
Granted 8,000 options to buy @ $0.95, valued at $7.6k
04/03/2019 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Sold 3,253 shares @ $0.9814, valued at $3.2k
02/06/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2018 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 250,000 options to buy @ $0.71, valued at $177.5k
01/05/2018 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 350,000 options to buy @ $1.24, valued at $434k
07/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2017 4 Chevallard Daniel R. (CFO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns: Granted 100,000 options to buy @ $1.65, valued at $165k
05/10/2017 3 Chevallard Daniel R. (CFO) has filed a Form 3 on Regulus Therapeutics Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy